{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:54:10Z","timestamp":1791572050360,"version":"4.3.4"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Dement."],"abstract":"<jats:p>Adult attention-deficit\/hyperactivity disorder (ADHD) is increasingly recognized as a persistent neurodevelopmental condition with long-term implications for cognitive aging and dementia risk. Epidemiological and longitudinal studies indicate that adults with ADHD have a higher incidence of non-amnestic dementia subtypes, including Lewy body disease, and may be particularly susceptible to age-related cognitive decline. Convergent mechanistic evidence implicates dopaminergic dysregulation, possible Wnt\/mTOR pathway alterations, oxidative stress, and chronic neuroinflammation as shared biological pathways linking ADHD to neurodegeneration. Psychiatric comorbidities, lifestyle factors, and reduced cognitive reserve may further amplify vulnerability, decreasing the brain\u2019s resilience to neuropathological insults. Preliminary data suggest that stimulant treatments, such as methylphenidate and amphetamine derivatives, may attenuate dementia risk by normalizing dopaminergic tone, enhancing cortical plasticity, and reducing oxidative stress, although randomized trials are needed to confirm these protective effects. Emerging biomarker and genetic studies, including polygenic ADHD risk scores, \u03b1-synuclein, amyloid\/tau, and GBA mutations, offer opportunities for early detection, risk stratification, and mechanistic insights. Integrating epidemiological, neuroimaging, molecular, and pharmacological data could guide targeted preventive interventions, highlighting ADHD as a developmental and potentially modifiable risk factor for late-life neurodegenerative disorders.<\/jats:p>","DOI":"10.3389\/frdem.2025.1735357","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T05:17:06Z","timestamp":1765862226000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Adult ADHD as a risk factor for dementia: integrating longitudinal evidence, mechanistic insights, and the role of stimulant treatment"],"prefix":"10.3389","volume":"4","author":[{"given":"Angel","family":"Golimstok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleska","family":"Berrios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s10548-011-0195-9","article-title":"Structural and functional imaging correlates of cognitive and brain reserve hypotheses in healthy and pathological aging","volume":"24","author":"Bartr\u00e9s-Faz","year":"2011","journal-title":"Brain Topogr."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1158546","DOI":"10.3389\/fpsyt.2023.1158546","article-title":"Risk of neurodegenerative disease or dementia in adults with attention-deficit\/hyperactivity disorder: a systematic review","volume":"14","author":"Becker","year":"2023","journal-title":"Front. Psych."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/pcn.13806","article-title":"Brain iron load and neuroaxonal vulnerability in adult attention-deficit hyperactivity disorder","volume":"79","author":"Berberat","year":"2025","journal-title":"Psychiatry Clin. Neurosci."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"17255","DOI":"10.1038\/s41598-025-02024-9","article-title":"Association between ADHD symptoms, physical effort discounting, and unhealthy lifestyles in adults","volume":"15","author":"Bernacer","year":"2025","journal-title":"Sci. Rep."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"4966","DOI":"10.1093\/hmg\/dds342","article-title":"LRRK2 functions as a Wnt signaling scaffold, bridging cytosolic proteins and membrane-localized LRP6","volume":"21","author":"Berwick","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1177\/10870547211060546","article-title":"Cognitive and neuroimaging profiles of older adults with attention deficit\/hyperactivity disorder presenting to a memory clinic","volume":"26","author":"Callahan","year":"2022","journal-title":"J. Atten. Disord."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1007\/s00415-020-10331-6","article-title":"Effect of cognitive reserve on structural and functional MRI measures in healthy subjects: a multiparametric assessment","volume":"268","author":"Conti","year":"2021","journal-title":"J. Neurol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.psyneuen.2017.02.017","article-title":"IL-6 and TNF-\u03b1 in unmedicated adults with ADHD: relationship to cortisol awakening response","volume":"79","author":"Corominas-Roso","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ejpn.2012.01.009","article-title":"The neurobiology and genetics of attention-deficit\/hyperactivity disorder (ADHD): what every clinician should know","volume":"16","author":"Cortese","year":"2012","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1358568","DOI":"10.3389\/fpsyt.2024.1358568","article-title":"Association between CNS-active drugs and risk of Alzheimer\u2019s and age-related neurodegenerative diseases","volume":"15","author":"Cortes-Flores","year":"2024","journal-title":"Front. Psych."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"7107","DOI":"10.1007\/s12035-015-9596-1","article-title":"Increased wnt signaling and reduced viability in a neuronal model of progranulin-deficient frontotemporal lobar degeneration","volume":"53","author":"de la Encarnaci\u00f3n","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.regg.2009.12.007","article-title":"Reserva cognitiva: evidencias, limitaciones y l\u00edneas de investigaci\u00f3n futura","volume":"45","author":"D\u00edaz-Orueta","year":"2010","journal-title":"Rev. Esp. Geriatr. Gerontol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1192\/j.eurpsy.2021.2261","article-title":"Attention-deficit\/hyperactivity disorder as a risk factor for dementia and mild cognitive impairment: a population-based register study","volume":"65","author":"Dobrosavljevic","year":"2021","journal-title":"Eur. Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.neubiorev.2021.01.022","article-title":"The world federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder","volume":"128","author":"Faraone","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.neuint.2017.08.005","article-title":"Antecedent ADHD, dementia, and metabolic dysregulation: a U.S. based cohort analysis","volume":"112","author":"Fluegge","year":"2018","journal-title":"Neurochem. Int."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1343314","DOI":"10.3389\/fpsyt.2024.1343314","article-title":"The impacts associated with having ADHD: an umbrella review","volume":"15","author":"French","year":"2024","journal-title":"Front. Psych."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1600-0447.2011.01786.x","article-title":"Meta-analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects: meta-analysis of structural MRI ADHD studies","volume":"125","author":"Frodl","year":"2012","journal-title":"Acta Psychiatr. Scand."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1212\/CON.0000000000001496","article-title":"Lewy body dementia","volume":"30","author":"Galvin","year":"2024","journal-title":"Continuum"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s12402-017-0219-8","article-title":"No genetic association between attention-deficit\/hyperactivity disorder (ADHD) and Parkinson\u2019s disease in nine ADHD candidate SNPs","volume":"9","author":"Geissler","year":"2017","journal-title":"Atten. Deficit Hyperact. Disord."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jagp.2024.04.005","article-title":"Adult attention deficit-hyperactivity disorder is associated with Lewy body disease and cognitive impairment: a prospective cohort study with 15-year follow-up","volume":"32","author":"Golimstok","year":"2024","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1468-1331.2010.03064.x","article-title":"Previous adult attention-deficit and hyperactivity disorder symptoms and risk of dementia with Lewy bodies: a case\u2013control study: ADHD and risk of dementia with Lewy body","volume":"18","author":"Golimstok","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1104985","DOI":"10.3389\/fnins.2023.1104985","article-title":"From attention-deficit hyperactivity disorder to sporadic Alzheimer\u2019s disease-Wnt\/mTOR pathways hypothesis","volume":"17","author":"Gr\u00fcnblatt","year":"2023","journal-title":"Front. Neurosci."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1042\/BST20180464","article-title":"The role of LRRK2 in cell signalling","volume":"47","author":"Harvey","year":"2019","journal-title":"Biochem. Soc. Trans."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1212\/WNL.0b013e3181b6bb95","article-title":"Systemic inflammation and disease progression in Alzheimer disease","volume":"73","author":"Holmes","year":"2009","journal-title":"Neurology"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1038\/s41380-022-01655-y","article-title":"Sleep, physical activity, sedentary behavior, and risk of incident dementia: a prospective cohort study of 431,924 UK biobank participants","volume":"27","author":"Huang","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.pnpbp.2014.02.002","article-title":"ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: implications for smoking and nicotine dependence","volume":"52","author":"Kollins","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41531-023-00534-9","article-title":"Substantia nigral dopamine transporter uptake in dementia with Lewy bodies","volume":"9","author":"Lee","year":"2023","journal-title":"NPJ Parkinson\u2019s Dis."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e70003","DOI":"10.1002\/alz.70003","article-title":"Impact of the polygenic risk scores for attention-deficit\/hyperactivity disorder in Alzheimer\u2019s disease","volume":"21","author":"Leffa","year":"2025","journal-title":"Alzheimers Dement."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e2338088","DOI":"10.1001\/jamanetworkopen.2023.38088","article-title":"Adult attention-deficit\/hyperactivity disorder and the risk of dementia","volume":"6","author":"Levine","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e225","DOI":"10.1017\/S0033291725101347","article-title":"Unraveling the phenotypic expression of ADHD symptoms in middle- and older-aged adults: insights from confirmatory factor analysis of the US health and retirement study","volume":"55","author":"Levine","year":"2025","journal-title":"Psychol. Med."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/wps.21020","article-title":"Attention-deficit\/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population-based cohort study","volume":"21","author":"Li","year":"2022","journal-title":"World Psychiatry"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13024-025-00879-0","article-title":"Lewy body dementia: exploring biomarkers and pathogenic interactions of amyloid \u03b2, tau, and \u03b1-synuclein","volume":"20","author":"Liang","year":"2025","journal-title":"Mol. Neurodegener."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1492126","DOI":"10.3389\/fpsyt.2024.1492126","article-title":"The dopamine hypothesis for ADHD: an evaluation of evidence accumulated from human studies and animal models","volume":"15","author":"MacDonald","year":"2024","journal-title":"Front. Psych."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3389\/fnagi.2014.00252","article-title":"Is dopamine involved in Alzheimer\u2019s disease?","volume":"6","author":"Martorana","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3389\/fnagi.2019.00175","article-title":"Dopamine and dopamine receptors in Alzheimer\u2019s disease: a systematic review and network meta-analysis","volume":"11","author":"Pan","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1176\/appi.ajp.2009.09040461","article-title":"Effects of chronic stress on memory decline in cognitively normal and mildly impaired older adults","volume":"166","author":"Peavy","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"101441","DOI":"10.1016\/j.disamonth.2022.101441","article-title":"Recent advances in Lewy body dementia: a comprehensive review","volume":"69","author":"Prasad","year":"2023","journal-title":"Dis. Mon."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13024-021-00428-5","article-title":"Mammalian\/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration","volume":"16","author":"Querfurth","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3390\/antiox12030581","article-title":"Progranulin deficiency induces mitochondrial dysfunction in frontotemporal lobar degeneration with TDP-43 inclusions","volume":"12","author":"Rodr\u00edguez-Peri\u00f1\u00e1n","year":"2023","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1002\/hbm.24585","article-title":"Differential regional decline in dopamine receptor availability across adulthood: linear and nonlinear effects of age","volume":"40","author":"Seaman","year":"2019","journal-title":"Hum. Brain Mapp."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e67595","DOI":"10.7759\/cureus.67595","article-title":"Hypothalamic-pituitary-adrenal (HPA) axis: unveiling the potential mechanisms involved in stress-induced Alzheimer\u2019s disease and depression","volume":"16","author":"Sharan","year":"2024","journal-title":"Cureus"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.neuropsychologia.2009.03.004","article-title":"Cognitive reserve","volume":"47","author":"Stern","year":"2009","journal-title":"Neuropsychologia"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/mds.28932","article-title":"GBA and APOE impact cognitive decline in Parkinson\u2019s disease: a 10-year population-based study","volume":"37","author":"Szwedo","year":"2022","journal-title":"Mov. Disord."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.neuropharm.2009.07.026","article-title":"Neurobiology of ADHD","volume":"57","author":"Tripp","year":"2009","journal-title":"Neuropharmacology"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1177\/1087054717714057","article-title":"Risk of dementia in adults with ADHD: a nationwide, population-based cohort study in Taiwan","volume":"23","author":"Tzeng","year":"2019","journal-title":"J. Atten. Disord."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"849323","DOI":"10.3389\/fncom.2022.849323","article-title":"A mechanistic model of ADHD as resulting from dopamine phasic\/tonic imbalance during reinforcement learning","volume":"16","author":"V\u00e9ronneau-Veilleux","year":"2022","journal-title":"Front. Comput. Neurosci."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1001\/jama.2009.1308","article-title":"Evaluating dopamine reward pathway in ADHD: clinical implications: clinical implications","volume":"302","author":"Volkow","year":"2009","journal-title":"JAMA"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s11065-023-09594-3","article-title":"Instruments to assess cognitive reserve among older adults: a systematic review of measurement properties","volume":"34","author":"Wei","year":"2024","journal-title":"Neuropsychol. Rev."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41398-020-00999-9","article-title":"The stress-Wnt-signaling axis: a hypothesis for attention-deficit hyperactivity disorder and therapy approaches","volume":"10","author":"Yde Ohki","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/alz.12462","article-title":"Attention-deficit\/hyperactivity disorder and Alzheimer\u2019s disease and any dementia: a multi-generation cohort study in Sweden","volume":"18","author":"Zhang","year":"2022","journal-title":"Alzheimers Dement."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3390\/ijms20030728","article-title":"Balancing mTOR signaling and autophagy in the treatment of Parkinson\u2019s disease","volume":"20","author":"Zhu","year":"2019","journal-title":"Int. J. Mol. Sci."}],"container-title":["Frontiers in Dementia"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frdem.2025.1735357\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T05:17:06Z","timestamp":1765862226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frdem.2025.1735357\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":51,"alternative-id":["10.3389\/frdem.2025.1735357"],"URL":"https:\/\/doi.org\/10.3389\/frdem.2025.1735357","relation":{},"ISSN":["2813-3919"],"issn-type":[{"value":"2813-3919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"article-number":"1735357"}}